The U.S. FDA approved Anacor Pharmaceuticals Inc.'s Eucrisa ointment to treat mild to moderate eczema in patients two years of age and older.

The safety and efficacy of the ointment were established in two placebo-controlled trials with participants from two years of age to 79 years of age, with mild to moderate atopic dermatitis.

Participants in the trial receiving Eucrisa achieved greater response with clear or almost clear skin after 28 days of treatment.